Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.
about
Phospholipase A(2) activation by poultry particulate matter is mediated through extracellular signal-regulated kinase in lung epithelial cells: regulation of interleukin-8 releaseOmega-3 fatty acids: potential role in the management of early Alzheimer's diseaseShotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodelingBee Venom Phospholipase A2: Yesterday's Enemy Becomes Today's FriendRNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndromeSignal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood DisordersMaintenance of synaptic stability requires calcium-independent phospholipase A₂ activityAn intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeksCytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.TBI and sex: crucial role of progesterone protecting the brain in an omega-3 deficient condition.Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.A secretory phospholipase A2-mediated neuroprotection and anti-apoptosis.Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death.Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Neuropathological responses to chronic NMDA in rats are worsened by dietary n-3 PUFA deprivation but are not ameliorated by fish oil supplementation.Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection.Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.Nutraceuticals in cognitive impairment and Alzheimer's disease.Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex.Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models.Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1.Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.Purification and characterization of a cytosolic Ca(2+)-independent phospholipase A(2) from bovine brain.Binge ethanol-induced neurodegeneration in rat organotypic brain slice cultures: effects of PLA2 inhibitor mepacrine and docosahexaenoic acid (DHA).Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged swordDocosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemiaFluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III TubulinOral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in ratsExposure to extremely low-frequency electromagnetic fields modulates Na+ currents in rat cerebellar granule cells through increase of AA/PGE2 and EP receptor-mediated cAMP/PKA pathway.Phospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairmentMode of action of mood stabilizers: is the arachidonic acid cascade a common target?Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease.Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.
P2860
Q23920909-B9CCE7B3-5CD2-462C-85B2-D2EB4F575D2DQ24595490-7BF64F27-B80C-47BF-B699-8FCD8F1560D8Q24645695-74EF3CFD-18B1-445B-AB1B-F9E29F99C3B1Q26767063-AB02EE3F-3CCF-445D-A22B-CE98493E50ECQ26992035-3E0A9114-040F-4524-A3A0-075169033B5DQ27006485-1A73C7FB-1B2E-468D-B4C4-C97FAE2389E4Q27027705-D1F8F0A9-7464-44BE-B1C5-7E2D2664299EQ27491346-D2DB79AC-558C-4273-99D2-9804B5D91947Q28578836-4CCB9D9F-55F6-44A0-82E9-D32515726801Q30484548-74221347-D440-427E-AB59-E082606DEDCFQ30577348-44531BD5-D3ED-4107-ACEA-54BF4D969A40Q30906677-95DD51C6-B9F9-448C-BD57-906268844FF9Q33506180-C1DA2FF9-B416-40BB-877C-0808B518E893Q33507174-ECC46965-50B7-49A8-AAAD-B3191487C47FQ33518442-48522C9D-07A9-4CC8-BDD2-63FA4F37AC8BQ33565825-5D3BF327-F60B-4740-9C1D-3DBAC9886574Q33567704-F25E5A44-27D5-4EDA-BA2D-8D259F9732B8Q33652546-A0A6FF1C-D63B-4F15-8277-0763F7568FF0Q33751063-9FCA89D4-0E59-442D-89C8-190232E6FBD8Q33784636-C5CE3814-63CD-4F03-B79A-35F43E1A2A3CQ33791503-B71F91EA-5FFB-47AB-BE7A-EF66F6EC1F28Q33813237-29BE3B33-382E-4DFA-90DE-35B5331B2FFAQ33853865-14A06727-8F7B-4F90-8A70-CC9FC2329085Q33912628-B7633510-DC7F-42DB-8B2C-FA95094374AFQ33993206-87C2E303-4B2A-4046-BC72-4AD2A3D40E9EQ33993276-642E9F2B-9182-4E0D-A63D-F79F58E21D60Q34004751-71B34603-6236-4787-938E-904C3E389FAFQ34010058-2B542C83-6E81-4279-91CF-F5DFF46570EEQ34027672-55BD5BBA-6CC3-4455-A322-858C82F20CE4Q34157706-752453F3-5CFF-4689-B065-863F24B2129AQ34363951-901003B4-0DF3-4855-9BFF-31046532A883Q34391633-C1D289EB-9476-4513-A769-4A7C658AD178Q34396359-ABFAE39C-A112-48DD-8518-85F4676F50E8Q34476283-994534F7-04A2-44B1-ABBD-258A1959DBC6Q34562987-74ED2303-BA77-47AF-B97F-4A2A57E6E0D6Q34630947-7FB0132C-6B57-492A-A978-B9B16CA070C1Q34762525-955A5C54-3E65-4F4B-AB3A-6685F855961AQ35048741-A64AF0B2-F754-403B-B886-F3D82D9271FFQ35094556-F7282307-3223-4FB4-BA7C-02FA756CB585Q35146962-C2F10199-73CC-4612-9B74-A168EEFA116F
P2860
Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@ast
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@en
type
label
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@ast
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@en
prefLabel
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@ast
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@en
P2093
P2860
P1476
Phospholipase A2 in the centra ...... or neurodegenerative diseases.
@en
P2093
Agnes Simonyi
Grace Y Sun
Jianfeng Xu
Michael D Jensen
P2860
P304
P356
10.1194/JLR.R300016-JLR200
P577
2003-12-01T00:00:00Z